E

Enveric Biosciences

ENVB

0.54000
USD
0.0701
(14.92%)
مغلق
حجم التداول
1
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
4,397,521
أصول ذات صلة
A
ALLO
-0.21500
(-7.29%)
2.73500 USD
A
APLS
-3.615
(-9.12%)
36.005 USD
B
BNTX
-5.530
(-6.42%)
80.570 USD
C
COLL
0.070
(0.18%)
38.620 USD
K
KMDA
-0.17000
(-3.01%)
5.48000 USD
K
KPTI
-0.06290
(-6.37%)
0.92380 USD
MRK
0.680
(0.60%)
113.800 USD
PFE
0.115
(0.38%)
30.650 USD
Z
ZYNE
0
(0%)
0.000000 USD
الأخبار المقالات

العنوان: Enveric Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, isa first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.